Company Comparison
Tessera Therapeutics vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tessera Therapeutics | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | San Diego |
| Founded | 2018 | — |
| Status | Active | Active |
| Last Funding Stage | Series B | Series A |
| Total Funding | $300M | $48M |
| Valuation | — | — |
What They Build
Tessera Therapeutics
Gene writing company developing a new class of genetic medicines that can write therapeutic messages into the genome to treat or cure diseases.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Tessera Therapeutics
AI Therapeutics
No investors listed.
Sector Overlap
Both Tessera Therapeutics and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.